FIELD: medicine.
SUBSTANCE: invention concerns medicine and pharmaceutics, and application of 4-hydroxytamoxifen in medicine preparation for treatment of benignant breast tumours, where the indicated medication takes form suitable for subcutaneous injection, and 4-hydroxytamoxifen is used in the form of hydroalcohol composition including isopropylmyristat as permeability amplification agent, water carrier, alcohol carrier and gelatinising agent.
EFFECT: enhanced permeability of 4-hydroxytamoxifen.
16 cl, 2 dwg, 7 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHEMICALLY STABLE COMPOSITIONS OF 4-HYDROXY-TAMOXIFEN | 2005 |
|
RU2389483C2 |
| CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (FOR INSTANCE, SERMS OR ALKYLATING AGENTS) | 2009 |
|
RU2543034C2 |
| TREATING VAGINAL ATROPHY IN FEMALES AT RISK OF TUMORAL PATHOLOGY | 2009 |
|
RU2504381C2 |
| COMPLEX THERAPY FOR CANCER TREATMENT | 2018 |
|
RU2810487C2 |
| PHARMACEUTICAL COMPOUND | 2008 |
|
RU2455990C2 |
| MEDICINAL PREPARATION CONTAINING AROMATASE STEROID INHIBITOR FOR PROPHYLAXIS AND/OR TREATMENT OF MAMMARY CANCER | 1999 |
|
RU2225206C2 |
| METHOD OF TREATING AND PREVENTING TUMOUR WHICH IS AMENABLE TO ENDOCRINE THERAPY, USING COMBINED USE OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND ENDOCRINE THERAPY | 2019 |
|
RU2825636C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PROLIFERATIVE MAMMARY GLAND DISEASES | 2005 |
|
RU2318508C2 |
| METHOD OF SENSITIZATION OF CANCER CELLS TO LYSIS MEDIATED BY KILLER-CELLS | 1994 |
|
RU2153332C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
